Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01949636 · ClinicalTrials.gov registry record
The Chocolate Study
A clinical trial of Obesity, sponsored by Oregon Research Institute.
- Completed
- Registry status
- 131
- Enrollment target
- 1
- Study location
NCT01949636: Completed study of Obesity, sponsored by Oregon Research Institute.
NCT01949636 is a study of Obesity that has completed, run by Oregon Research Institute. The registered enrollment target is 131 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01949636, a study of Obesity, has completed, sponsored by Oregon Research Institute.
- COMPLETED
- Registry status
- 131 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to test the dynamic vulnerability model of obesity using brain imaging.
Primary Outcome
Whether increases in BMI are predicted by: elevated reward region responsivity and reduced inhibitory region responsivity to palatable food varying in sugar/fat content (measured during fMRI scan)
Conditions Studied
Interventions
- OTHER Functional Magnetic Resonance Imaging
Study Locations (1)
Oregon
- Oregon Research Institute - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 131 participants |
| Start Date | 2012-05 |
| Est. Completion | 2018-04 |
What the finished NCT01949636 record still lists
NCT01949636 is an observational study that tracks outcomes without assigning an intervention. The registered 131 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (84% lower).
The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Functional Magnetic Resonance Imaging is the first listed.
NCT01949636 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT01949636 about?
NCT01949636 is a clinical study titled "The Chocolate Study". The purpose of this study is to test the dynamic vulnerability model of obesity using brain imaging.
What is the current status of trial NCT01949636?
This trial is currently completed. The enrollment target is 131 participants. The study started on 2012-05. Estimated completion is 2018-04.
What conditions does trial NCT01949636 study?
This clinical trial studies the following conditions: Obesity.
What interventions are being tested in trial NCT01949636?
The interventions under investigation include: Functional Magnetic Resonance Imaging (OTHER).
Who is sponsoring clinical trial NCT01949636?
This trial is sponsored by Oregon Research Institute, which has 62 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01949636 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01949636's enrollment target sits among peer trials
131 417th of 1053 higher than 637 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03051464 · 131 participants · Phase 2
No Surgery Trial / Two Dose-escalation Strategies
- NCT04301843 · 131 participants · Phase 2
Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma
- NCT04748549 · 131 participants · NA
Intraoperative VR for Older Patients Undergoing TKA
- NCT05951179 · 131 participants · Phase 2
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia